CalciMedica (CALC) Change in Accured Expenses (2019 - 2026)

CalciMedica (CALC) has 8 years of Change in Accured Expenses data on file, last reported at -$232000.0 in Q1 2026.

• Quarterly Change in Accured Expenses fell 130.69% year-over-year to -$232000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (down 486.1% YoY) and the FY2025 annual result came in at -$319000.0, up 63.25% from the prior year.
• Change in Accured Expenses advanced to -$232000.0 in Q1 2026, from -$1.2 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $6.8 million in Q1 2023 to a low of -$8.8 million in Q2 2023.
• A 5-year average of -$120823.5 and a median of $72000.0 in 2023 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses jumped 1855.0% — and 2023, when it slumped 3688.31%.
• Tracing CALC's Change in Accured Expenses over 5 years: stood at $782000.0 in 2022, then tumbled by 90.15% to $77000.0 in 2023, then slumped by 755.84% to -$505000.0 in 2024, then plunged by 133.47% to -$1.2 million in 2025, then jumped by 80.32% to -$232000.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$232000.0 (Q1 2026), -$1.2 million (Q4 2025), and $981000.0 (Q3 2025), per Business Quant data.